Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aryl hydrocarbon receptor and intestinal immunity
Bruno Lamas, Jane M. Natividad, Harry Sokol
Mucosal Immunology (2018) Vol. 11, Iss. 4, pp. 1024-1038
Open Access | Times Cited: 420

Showing 1-25 of 420 citing articles:

Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease
Allison Agus, Julien Planchais, Harry Sokol
Cell Host & Microbe (2018) Vol. 23, Iss. 6, pp. 716-724
Open Access | Times Cited: 2082
Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome
Jane M. Natividad, Allison Agus, Julien Planchais, et al.
Cell Metabolism (2018) Vol. 28, Iss. 5, pp. 737-749.e4
Open Access | Times Cited: 494
Inflammation–Nature's Way to Efficiently Respond to All Types of Challenges: Implications for Understanding and Managing “the Epidemic” of Chronic Diseases
Jeanette M. Bennett, Glenn Reeves, George E. Billman, et al.
Frontiers in Medicine (2018) Vol. 5
Open Access | Times Cited: 427
AHR in the intestinal microenvironment: safeguarding barrier function
Brigitta Stockinger, Kathleen Shah, Emma Wincent
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 8, pp. 559-570
Open Access | Times Cited: 252
Tryptophan Metabolism as a Pharmacological Target
Morgane Modoux, Nathalie Rolhion, Sridhar Mani, et al.
Trends in Pharmacological Sciences (2020) Vol. 42, Iss. 1, pp. 60-73
Open Access | Times Cited: 225
Tryptophan in health and disease
Stefano Comai, Antonella Bertazzo, Martina Brughera, et al.
Advances in clinical chemistry (2020), pp. 165-218
Closed Access | Times Cited: 221
Microbiota-derived metabolites as drivers of gut–brain communication
Hany Ahmed, Quentin Leyrolle, Ville Koistinen, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 211
Indole-3-lactic acid associated with Bifidobacterium-dominated microbiota significantly decreases inflammation in intestinal epithelial cells
Amy M. Ehrlich, Alline R. Pacheco, Bethany M. Henrick, et al.
BMC Microbiology (2020) Vol. 20, Iss. 1
Open Access | Times Cited: 194
Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice
Seung‐Chul Choi, Josephine Brown, Minghao Gong, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 551
Open Access | Times Cited: 192
Dysbiosis signatures of gut microbiota in coronary artery disease
Qi Zhu, Renyuan Gao, Yi Zhang, et al.
Physiological Genomics (2018) Vol. 50, Iss. 10, pp. 893-903
Open Access | Times Cited: 176
Polystyrene Nanoplastics Toxicity to Zebrafish: Dysregulation of the Brain–Intestine–Microbiota Axis
Miaomiao Teng, Xiaoli Zhao, Chengju Wang, et al.
ACS Nano (2022) Vol. 16, Iss. 5, pp. 8190-8204
Closed Access | Times Cited: 174
New Insights Into Gut-Bacteria-Derived Indole and Its Derivatives in Intestinal and Liver Diseases
Xiaojing Li, Binbin Zhang, Yiyang Hu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 143
Aryl hydrocarbon receptor ligand production by the gut microbiota is decreased in celiac disease leading to intestinal inflammation
Bruno Lamas, Leticia Hernández-Galán, Heather J. Galipeau, et al.
Science Translational Medicine (2020) Vol. 12, Iss. 566
Open Access | Times Cited: 139
Dual Role of Indoles Derived From Intestinal Microbiota on Human Health
Xuewei Ye, Haiyi Li, Komal Anjum, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 125
Microbiome-based interventions to modulate gut ecology and the immune system
Thomas C. A. Hitch, Lindsay J. Hall, Sarah Kate Walsh, et al.
Mucosal Immunology (2022) Vol. 15, Iss. 6, pp. 1095-1113
Open Access | Times Cited: 108
Indole-3-Acetic Acid Alters Intestinal Microbiota and Alleviates Ankylosing Spondylitis in Mice
Jun Shen, Lianjun Yang, Ke You, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 105
Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan Metabolism
Hao Cheng, Juan Liu, Dandan Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 82
The Role of Diet and Gut Microbiota in Regulating Gastrointestinal and Inflammatory Disease
Paul A. Gill, S Inniss, Tomoko Kumagai, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 80
Microplastics: What happens in the human digestive tract? First evidences in adults using in vitro gut models
E Fournier, Mathilde Lévêque, Philippe Ruiz, et al.
Journal of Hazardous Materials (2022) Vol. 442, pp. 130010-130010
Open Access | Times Cited: 77
Gut microbiota-motility interregulation: insights from in vivo, ex vivo and in silico studies
Barbora Waclawiková, Agnese Codutti, Karen Alim, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 70
The role of transcription factors in shaping regulatory T cell identity
Jorge L. Trujillo‐Ochoa, Majid Kazemian, Behdad Afzali
Nature reviews. Immunology (2023) Vol. 23, Iss. 12, pp. 842-856
Closed Access | Times Cited: 59
Activation of aryl hydrocarbon receptor (AhR) in Alzheimer’s disease: role of tryptophan metabolites generated by gut host-microbiota
Antero Salminen
Journal of Molecular Medicine (2023) Vol. 101, Iss. 3, pp. 201-222
Open Access | Times Cited: 56
Colonization and development of the gut microbiome in calves
Yufeng Du, Ya Gao, Mingyang Hu, et al.
Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 56
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation
Byeong Hyun Min, Shivani Devi, Goo Hyun Kwon, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 33
Gut-liver axis: Pathophysiological concepts and medical perspective in chronic liver diseases
Susana Rodrigues, Van der Merwe, Aleksander Krag, et al.
Seminars in Immunology (2024) Vol. 71, pp. 101859-101859
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top